Hey guys and gals,
If you have been watching or trading MYMD the last few weeks, it has been a painful reminder that high-flying stocks can also come back down just as quickly.
The good news is that MYMD is trading back at key support levels not seen since earlier this year. If you recall, we started bringing MYMD to your attention in July when the stock was around the same levels it is right now.
In the weeks that followed, MYMD shot up from those depressed levels and rallied over 200% at one point.
I just want to bring this to your attention. Some of the biggest rallies come from oversold levels.
If you are looking to get involved with a stock do you want to get started at overbought levels or oversold levels?
Personally, I would rather buy stocks that are oversold and sitting right at key support levels. That’s exactly where we are with MYMD right now.
That’s my take on the trading right now — however it’s always a good thing to get back to the main course…
Which is MYMD-1’s positioning to treat sarcopenia and frailty—aka all those negative physical effects associated with aging.
Anyone who’s over 30 knows what I am talking about — those little nagging aches and pains that used to go away when you were younger seem to be a part of everyday life as you get older.
Well, most of these are caused by inflammation in your joints and no amount of expensive creams, lotions or magical silver-lined socks you might see on TV are going to help fix it.
But what if we could fix those aches and pains that plague us as we age?
To investigate this, the root of the problem lies in a little-known protein called “TNF-alpha” which is a key player associated with pathological aging.
Therapies that block TNF-alpha are widely prescribed and in fact are one of the most prescribed drugs by revenue in the world – expected to reach almost $43 billion in 2023!
Yes. That is “B” as in BILLIONS. $43 billion… and growing every year.
These drugs are used in general because they help people’s joints feel better – and who doesn’t want to feel better?
However, current TNF-alpha blockers only treat the symptoms of aging, not the causes.
And this, my friend, is where my favorite biotech, MyMD, enters the picture…
MyMD is seeking to not only make you feel better but to actually slow down the aging process and extend healthy lifespan with its leading drug candidate, MYMD-1.
MYMD-1 is currently progressing through its Phase 2 FDA trial, with the aim of addressing the aging crisis with real science from some of the best scientists in the world.
If you want to know more about this age-defying company and all the exciting potential it has to offer, check out my detailed report here.
*THIS IS AN ISSUER-PAID ADVERTISEMENT, SEE DISCLOSURE BELOW
*ISSUER-PAID ADVERTISEMENT. MyMD, Inc. (“MYMD” or the “Company”) HAS PAID OR
WILL PAY SHERWOOD VENTURES, LLC (“Sherwood”) TWENTY-THOUSAND DOLLARS USD PER MONTH FOR THREE MONTHS (THE “INITIAL TERM”) IN CASH, SHARES OF RESTRICTED COMMON STOCK WITH A VALUE OF ONE-HUNDRED-FIFTY THOUSAND DOLLARS, AND WARRANTS VALUED AT ISSUANCE OF SEVENTY-FIVE THOUSAND DOLLARS FOR MARKETING SERVICES INCLUDING COMMUNICATING TO THE PUBLIC ABOUT THE COMPANY THROUGH SHERWOOD’S AFFILIATE RAGINGBULL.COM, LLC (“RAGING BULL”), AMONG OTHERS. THIS ADVERTISEMENT IS PART OF THOSE ISSUER-PAID MARKETING SERVICES. FOR DETAILED COMPENSATION AND MORE INFORMATION, PLEASE SEE THE FULL DISCLOSURE LOCATED AT HTTPS://BOARDROOMINVESTING.COM/MYMD-DISCLAIMER.
|*THIS IS AN ISSUER-PAID ADVERTISEMENT FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT
ADVICE. This advertisement is for educational and informational purposes only. All material
information contained in this advertisement is based on information generally available to the
public, which public information is believed to be reliable and accurate. Nevertheless, neither
Sherwood nor Raging Bull can guarantee the accuracy or completeness of the information. This
advertisement does not purport to be a complete analysis of any company’s financial position.
This advertisement or any statements made in it is not, and should not be construed to be,
personalized investment advice directed to or appropriate for any particular individual. The
statements made in this advertisement should NOT be relied upon for purposes of investing
in the companies mentioned in this advertisement, nor should they be construed as a
personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this advertisement or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any
*Substantil Risk Involved Any individual who chooses to invest in any securities of
the companies mentioned i this advertisement should do so with caution. Investing or
transacting in any securities involves substantial risk; you may lose some, all, or possibly
more than your original investment. Readers of this advertisement bear responsibility for
their own investment research and decisions and should use information from this
advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or
registered professional and educating yourself as much as possible before considering any
*Not an Investment Advisoror Registered Broker NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither Sherwood nor
Raging Bull or any of its owners, employees or independent contractors is currently registered
as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S.
Securities and Exchange Commission, any state securities regulatory authority, or any self-
*Use of Forward -looking statements USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this
advertisement may constitute forward-looking statements within the meaning of Section 27A of
the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements
often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,”
“intends,” or other similar expressions of future performance or conduct. Forward-looking
statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated.
There is no guarantee that past performance will be indicative of future results. Raging Bull
does not undertake an obligation to update forward-looking statements in light of new
information or future events. Readers can and should review all public SEC filings made by the
companies profiled in the Advertisements at https://www.sec.gov/edgar/browse/?CIK=1321834&owner=exclude.
*Trademarks TRADEMARKS. All trademarks used in this advertisement are the property of their respective
trademark holders and no endorsement by such owners of the contents of the advertisement is
made or implied.
DISCLAIMER: To more fully understand any Ragingbull.com, LLC (“RagingBull”) subscription, website, application or other service (“Services”), please review our full disclaimer located at https://ragingbull.com/disclaimer.
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.
RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers’ trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.
RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of RagingBull.com, LLC are paid in whole or in part by commission based on their sales of Services to subscribers.
WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.